Skip to main content
. 2022 Apr 5;109(6):530–538. doi: 10.1093/bjs/znac077

Table 4.

Three-month outcomes after prepectoral breast reconstruction compared with outcomes in the iBRA study

Pre-BRA study
(n = 343)
iBRA study
(n = 2081)
Readmission 60 (17.5; 13.5, 21.5) 372 (18; 16–20)
Reoperation 55 (16.0; 12.1, 19.9) 372 (18; 16–20)
Infection 67 (19.5; 15.3, 23.8) 522 (25; 23–27)
Implant loss* 28 (8.2; 5.3, 11.1) 182 (9; 8, 10)
Any complication 144 (42.0; 36.7, 47.2)

Values in parentheses are percentages with 95 per cent confidence intervals. *Total removal of implant/expander without replacement. There were 11 additional patients in whom successful implant salvage (with a tissue expander or implant) was performed. Salvage was unsuccessful in one; this is included as a total implant loss at 3 months.